Mergers & Acquisitions Mergers & Acquisitions

EQT files Dechra acquisition for EU review

By Natalie McNelis
  • 17 Nov 2023 16:54
  • 17 Nov 2023 16:54
Investment company EQT has requested EU approval to acquire the veterinary pharmaceuticals specialist Dechra, according to an update this evening on the European Commission's register of deals.
The regulator has set a Dec. 22 deadline to decide on the 4.5 billion-pound ($5.6 billion) takeover.

EQT Partners is a Swedish global

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent

Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

Latest News